NRBO Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | 2021 | Gil Price Former President and Chief Executive Officer | 66,154 | 0 | 0 | 0 | 0 | 920,276 |
| 2023-05-26 | 2022 | Gil Price Former President and Chief Executive Officer | 400,000 | 100,000 | 0 | 0 | 0 | 500,000 |
| 2022-11-28 | 2020 | Gil Price President, and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022-11-28 | 2020 | Akash Bakshi Former Chief Operating Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022-11-28 | 2021 | Akash Bakshi Former Chief Operating Officer | 250,000 | 0 | 0 | 0 | 125,000 | 375,000 |
| 2022-11-28 | 2020 | Richard Kang Former President and Chief Executive Officer | 302,308 | 125,000 | 0 | 0 | 0 | 427,308 |
| 2022-11-28 | 2021 | Richard Kang Former President and Chief Executive Officer | 260,769 | 130,680 | 0 | 0 | 160,000 | 551,449 |
| 2022-11-28 | 2021 | Gil Price President, and Chief Executive Officer | 66,154 | 0 | 0 | 0 | 0 | 920,276 |
| 2022-05-18 | 2021 | Ben Gil Price President, and Chief Executive Officer | 66,154 | 0 | 0 | 0 | 0 | 920,276 |
| 2022-05-18 | 2020 | Richard Kang Former President and Chief Executive Officer | 302,308 | 125,000 | 0 | 0 | 0 | 427,308 |
| 2022-05-18 | 2021 | Akash Bakshi Former Chief Operating Officer | 250,000 | 0 | 0 | 0 | 125,000 | 375,000 |
| 2022-05-18 | 2020 | Akash Bakshi Former Chief Operating Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022-05-18 | 2021 | Richard Kang Former President and Chief Executive Officer | 260,769 | 130,680 | 0 | 0 | 160,000 | 551,449 |
| 2022-05-18 | 2020 | Ben Gil Price President, and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-06-15 | 2020 | Richard Kang President, Chief Executive Officer, Interim Chief Financial Officer, Secretary and Treasurer | 302,308 | 125,000 | 0 | 0 | 0 | 427,308 |
| 2021-06-15 | 2019 | Richard Kang President, Chief Executive Officer, Interim Chief Financial Officer, Secretary and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-06-15 | 2020 | Dr. Mark Versavel Former Chief Medical Officer | 357,000 | 0 | 0 | 0 | 0 | 357,000 |
| 2021-06-15 | 2019 | Dr. Mark Versavel Former Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-06-15 | 2020 | Nicola Shannon Former Vice President, Clinical Operations | 281,750 | 52,500 | 0 | 0 | 0 | 334,250 |
| 2021-06-15 | 2019 | Nicola Shannon Former Vice President, Clinical Operations | 0 | 66,250 | 0 | 0 | 0 | 66,250 |
| 2020-04-29 | 2018 | Seth Reno Former Chief Commercial Officer | 275,000 | 0 | 0 | 0 | 10,566 | 583,805 |
| 2020-04-29 | 2019 | Seth Reno Former Chief Commercial Officer | 263,543 | 0 | 72,000 | 0 | 308,732 | 644,275 |
| 2020-04-29 | 2018 | Charles L. Bisgaier, Ph.D. Former Chief Scientific Officer | 330,000 | 0 | 0 | 0 | 11,183 | 639,423 |
| 2020-04-29 | 2019 | Charles L. Bisgaier, Ph.D. Former Chief Scientific Officer | 261,159 | 0 | 72,000 | 0 | 340,585 | 673,744 |
| 2020-04-29 | 2019 | Steven Gullans, Ph.D. Former President and Chief Executive Officer | 381,249 | 0 | 216,000 | 0 | 102,419 | 699,668 |
| 2020-04-29 | 2018 | Steven Gullans, Ph.D. Former President and Chief Executive Officer | 346,932 | 250,000 | 0 | 0 | 6,751 | 1,902,821 |
| 2020-04-29 | 2019 | Nicola Shannon Vice President, Clinical Operations | 0 | 66,250 | 0 | 0 | 0 | 66,250 |
| 2020-04-29 | 2019 | Dr. Mark Versavel Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-04-17 | 2016 | Steven Gullans, Ph.D. Interim President and Chief Executive Officer | 0 | 0 | 0 | 0 | 23,831 | 402,893 |
| 2018-04-17 | 2017 | Steven Gullans, Ph.D. Interim President and Chief Executive Officer | 30,376 | 0 | 0 | 0 | 23,575 | 407,215 |
| 2018-04-17 | 2016 | Charles L. Bisgaier, Ph.D. Chief Scientific Officer | 300,000 | 54,000 | 0 | 90,000 | 97 | 1,391,753 |
| 2018-04-17 | 2017 | Charles L. Bisgaier, Ph.D. Chief Scientific Officer | 330,000 | 30,000 | 0 | 0 | 258 | 360,258 |
| 2018-04-17 | 2016 | Mina Sooch Former President and Chief Executive Officer | 380,645 | 102,500 | 0 | 159,375 | 226 | 4,433,370 |
| 2018-04-17 | 2017 | Mina Sooch Former President and Chief Executive Officer | 177,823 | 0 | 0 | 0 | 550,107 | 727,930 |
| 2018-04-17 | 2016 | Lee Golden, Ph.D. Chief Medical Officer | 83,737 | 20,000 | 0 | 26,250 | 93 | 1,003,292 |
| 2018-04-17 | 2017 | Lee Golden, Ph.D. Chief Medical Officer | 365,000 | 39,000 | 0 | 0 | 258 | 538,128 |
| 2017-04-06 | 2015 | Charles L. Bisgaier, Ph.D. Chief Scientific Officer | 270,000 | 0 | 0 | 0 | 0 | 273,436 |
| 2017-04-06 | 2015 | Mina Sooch President and Chief Executive Officer | 315,000 | 0 | 0 | 0 | 0 | 319,009 |
| 2017-04-06 | 2016 | Mina Sooch President and Chief Executive Officer | 380,645 | 102,500 | 0 | 159,375 | 226 | 4,433,370 |
| 2017-04-06 | 2016 | Charles L. Bisgaier, Ph.D. Chief Scientific Officer | 300,000 | 54,000 | 0 | 90,000 | 97 | 1,391,753 |
| 2017-04-06 | 2015 | Jeffrey S. Mathiesen Chief Financial Officer | 104,833 | 0 | 0 | 0 | 0 | 220,798 |
| 2017-04-06 | 2016 | Jeffrey S. Mathiesen Chief Financial Officer | 280,645 | 15,000 | 0 | 97,500 | 97 | 1,719,960 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
